Related Experiment Video

Updated: Dec 10, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.6K

Molecular Mechanisms Underlying the Cardiovascular Toxicity of Specific Uremic Solutes

Jonathan D Ravid1, Vipul C Chitalia1,2,3

  • 1Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.

Cells
|September 5, 2020
PubMed

Insights

Chronic kidney disease (CKD) patients face higher cardiovascular disease (CVD) risks due to uremic toxins. Understanding these toxins

Area of Science:

  • Nephrology
  • Cardiology
  • Toxicology

Background:

  • Chronic kidney disease (CKD) is strongly linked to cardiovascular disease (CVD).
  • CKD patients experience worse CVD outcomes and reduced benefit from standard treatments.
  • Uremic toxins (UTs) accumulate in CKD and uniquely impact cardiovascular health.

Purpose of the Study:

  • To review the effects of specific UTs on cardiovascular health pathways.
  • To explore molecular mechanisms of UTs in CVD progression in CKD.
  • To identify potential therapeutic targets for managing CVD in CKD patients.

Main Methods:

  • Literature review of current knowledge on UTs and CVD.
  • Analysis of molecular mechanisms linking UTs to cardiovascular dysfunction.
  • Survey of studies on tryptophan metabolites and trimethylamine N-oxide as cardiovascular toxins.

Main Results:

  • UTs significantly impact various pathways and cell functions crucial for cardiovascular integrity.
  • Specific UTs like tryptophan metabolites and trimethylamine N-oxide are identified as potent cardiovascular toxins.
  • The cross-organ effects of UTs highlight a complex interplay between kidney and heart pathologies.

Conclusions:

  • Uremic toxins represent a critical, unique risk factor for cardiovascular disease in chronic kidney disease.
  • Deciphering UT molecular mechanisms is essential for developing novel therapeutic strategies.
  • Targeting UTs could improve cardiovascular outcomes for patients with chronic kidney disease.

Keywords:
cardiovascular diseasechronic kidney diseaseuremic toxins

More Related Videos

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions06:32

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions

Published on: June 13, 2025

362
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

24.2K

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
410
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
674
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
737
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
112
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.1K
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
746